The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators and Teva Pharmaceutical.
Price target cuts across the board, ratings mostly unchanged.
Steven M. Peters Full interview with instant commentary by Wedbush's Dan Ives and Loup Ventures' Gene Munster.
Steven M. Peters When Apple released a letter from CEO Tim Cook to investors, among the most important comments was that sales in China were the most serious barrier to better results.
Douglas A. McIntyre "Today we are revising our guidance for Apple’s fiscal 2019 first quarter."
Steven M. Peters CEO Tim Cook has announced the most recent quarter fell apart, by Apple's standards, and there may be worse ahead.
Douglas A. McIntyre “For Amazon and for Apple there are reasons to believe the sell-off is overdone.” — D.A. Davidson’s Tom Forte From CNBC’s Squawk on the Street Wednesday morning: For…
Steven M. Peters From a note to clients that landed on my desktop Wednesday.
Steven M. Peters See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average in 2019.
From David Streitfeld's "Big Tech May Look Troubled, but It’s Just Getting Started" in Wednesday's New York Times.
Steven M. Peters From Value Line's Dec. 28 report on Apple.
Steven M. Peters Localytics: The iPhone XR had a great Christmas, but not as great as the iPad.
Steven M. Peters “It appears that iPhone XR did serve to attract current Android users,” — Mike Levin, CIRP co-founder From iPhone XR Takes 32% of Sales in First Month of…
Steven M. Peters "We believe shares of AAPL have been unduly punished on apocalyptic demand concerns." —Analyst Daniel Ives
Steven M. Peters "The zombie isn’t a particularly good evaluator of stocks."
Steven M. Peters 
